

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.77344883 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.77344883 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.69605629 |
| 4 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.03078983 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.00026301 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.85863365 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.40621313 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 4.29875957 |
| 9 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.16340038 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.07447682 |
| 11 | immunoglobulin mediated immune response (GO:0016064) | 3.88839070 |
| 12 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.84564533 |
| 13 | cellular extravasation (GO:0045123) | 3.83162439 |
| 14 | positive regulation of B cell differentiation (GO:0045579) | 3.78609070 |
| 15 | histone H3-K4 trimethylation (GO:0080182) | 3.75712770 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.73362757 |
| 17 | negative regulation of cell killing (GO:0031342) | 3.73362757 |
| 18 | detection of other organism (GO:0098543) | 3.72807112 |
| 19 | cellular response to interleukin-15 (GO:0071350) | 3.70975814 |
| 20 | detection of bacterium (GO:0016045) | 3.70207960 |
| 21 | positive regulation of granulocyte differentiation (GO:0030854) | 3.62444783 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.53182798 |
| 23 | negative regulation of T cell mediated immunity (GO:0002710) | 3.51423489 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.42025921 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.42025921 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.42025921 |
| 27 | positive regulation by symbiont of host defense response (GO:0052509) | 3.42025921 |
| 28 | modulation by symbiont of host defense response (GO:0052031) | 3.42025921 |
| 29 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.42025921 |
| 30 | B cell receptor signaling pathway (GO:0050853) | 3.41928043 |
| 31 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.40488329 |
| 32 | regulation of B cell differentiation (GO:0045577) | 3.36990572 |
| 33 | regulation of germinal center formation (GO:0002634) | 3.35272664 |
| 34 | microglial cell activation (GO:0001774) | 3.31857888 |
| 35 | response to peptidoglycan (GO:0032494) | 3.31601857 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.31535395 |
| 37 | leukocyte aggregation (GO:0070486) | 3.25347303 |
| 38 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.24961603 |
| 39 | regulation of regulatory T cell differentiation (GO:0045589) | 3.24329687 |
| 40 | valine metabolic process (GO:0006573) | 3.23457237 |
| 41 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.20267580 |
| 42 | neutrophil activation (GO:0042119) | 3.19615070 |
| 43 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.16909425 |
| 44 | positive regulation of respiratory burst (GO:0060267) | 3.15695330 |
| 45 | activated T cell proliferation (GO:0050798) | 3.15642841 |
| 46 | regulation of histone H3-K27 methylation (GO:0061085) | 3.13441719 |
| 47 | germinal center formation (GO:0002467) | 3.11461016 |
| 48 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10605023 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.08835655 |
| 50 | regulation of antigen processing and presentation (GO:0002577) | 3.08566697 |
| 51 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.07603133 |
| 52 | response to type I interferon (GO:0034340) | 3.03596815 |
| 53 | detection of external biotic stimulus (GO:0098581) | 3.03080107 |
| 54 | neutrophil mediated immunity (GO:0002446) | 3.02966316 |
| 55 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.02677150 |
| 56 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.02365825 |
| 57 | mast cell activation (GO:0045576) | 3.01146180 |
| 58 | B cell mediated immunity (GO:0019724) | 3.00571311 |
| 59 | cellular response to type I interferon (GO:0071357) | 2.97589940 |
| 60 | type I interferon signaling pathway (GO:0060337) | 2.97589940 |
| 61 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.95870600 |
| 62 | myeloid cell activation involved in immune response (GO:0002275) | 2.95783520 |
| 63 | negative regulation of interleukin-12 production (GO:0032695) | 2.95383957 |
| 64 | positive thymic T cell selection (GO:0045059) | 2.94347970 |
| 65 | tolerance induction (GO:0002507) | 2.92988844 |
| 66 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.92915791 |
| 67 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.92915791 |
| 68 | macrophage activation involved in immune response (GO:0002281) | 2.92908440 |
| 69 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.92719965 |
| 70 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.90548958 |
| 71 | mannose metabolic process (GO:0006013) | 2.89797313 |
| 72 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.88857308 |
| 73 | negative regulation of adaptive immune response (GO:0002820) | 2.87431637 |
| 74 | regulation of beta-amyloid formation (GO:1902003) | 2.85116551 |
| 75 | defense response to protozoan (GO:0042832) | 2.84690317 |
| 76 | regulation of mast cell activation (GO:0033003) | 2.82950336 |
| 77 | mast cell degranulation (GO:0043303) | 2.81404045 |
| 78 | mast cell activation involved in immune response (GO:0002279) | 2.81404045 |
| 79 | negative regulation of innate immune response (GO:0045824) | 2.80226772 |
| 80 | regulation of mast cell degranulation (GO:0043304) | 2.78677986 |
| 81 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.77683676 |
| 82 | granulocyte activation (GO:0036230) | 2.76428245 |
| 83 | regulation of tolerance induction (GO:0002643) | 2.75939528 |
| 84 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.75592523 |
| 85 | response to host immune response (GO:0052572) | 2.75592523 |
| 86 | secretory granule organization (GO:0033363) | 2.74510246 |
| 87 | T cell receptor signaling pathway (GO:0050852) | 2.74411327 |
| 88 | regulation of memory T cell differentiation (GO:0043380) | 2.74308697 |
| 89 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.72676811 |
| 90 | cellular response to exogenous dsRNA (GO:0071360) | 2.70614276 |
| 91 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.70116885 |
| 92 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.70116885 |
| 93 | positive regulation of histone deacetylation (GO:0031065) | 2.69651068 |
| 94 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.69064874 |
| 95 | negative T cell selection (GO:0043383) | 2.67943756 |
| 96 | negative regulation of stress fiber assembly (GO:0051497) | 2.66043751 |
| 97 | positive regulation of natural killer cell activation (GO:0032816) | 2.65550356 |
| 98 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.65211437 |
| 99 | myeloid leukocyte mediated immunity (GO:0002444) | 2.64228273 |
| 100 | response to protozoan (GO:0001562) | 2.62159332 |
| 101 | T cell homeostasis (GO:0043029) | 2.61924435 |
| 102 | regulation of granulocyte differentiation (GO:0030852) | 2.61175437 |
| 103 | megakaryocyte development (GO:0035855) | 2.60638790 |
| 104 | regulation of cellular amide metabolic process (GO:0034248) | 2.60541796 |
| 105 | negative thymic T cell selection (GO:0045060) | 2.56282818 |
| 106 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.55959195 |
| 107 | Golgi to endosome transport (GO:0006895) | 2.55836421 |
| 108 | positive T cell selection (GO:0043368) | 2.55720724 |
| 109 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.54530395 |
| 110 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.52598180 |
| 111 | response to interleukin-15 (GO:0070672) | 2.51520715 |
| 112 | T cell migration (GO:0072678) | 2.51227038 |
| 113 | Peyers patch development (GO:0048541) | 2.49123194 |
| 114 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.49123194 |
| 115 | definitive hemopoiesis (GO:0060216) | 2.46262467 |
| 116 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.45554700 |
| 117 | adaptation of signaling pathway (GO:0023058) | 2.45063246 |
| 118 | tricarboxylic acid metabolic process (GO:0072350) | 2.44998867 |
| 119 | response to interferon-alpha (GO:0035455) | 2.44133281 |
| 120 | necroptotic process (GO:0070266) | 2.41985706 |
| 121 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.41340671 |
| 122 | regulation of natural killer cell activation (GO:0032814) | 2.40966678 |
| 123 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.40356260 |
| 124 | regulation of erythrocyte differentiation (GO:0045646) | 2.38353522 |
| 125 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.36640581 |
| 126 | interferon-gamma production (GO:0032609) | 2.35924712 |
| 127 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.35780977 |
| 128 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.34094925 |
| 129 | programmed necrotic cell death (GO:0097300) | 2.32262014 |
| 130 | leukocyte homeostasis (GO:0001776) | 2.31725230 |
| 131 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.31651112 |
| 132 | positive regulation of antigen processing and presentation (GO:0002579) | 2.31540531 |
| 133 | beta-amyloid metabolic process (GO:0050435) | 2.31035185 |
| 134 | negative regulation of interleukin-17 production (GO:0032700) | 2.30734181 |
| 135 | lymphocyte homeostasis (GO:0002260) | 2.30223466 |
| 136 | T cell selection (GO:0045058) | 2.27177555 |
| 137 | lymph node development (GO:0048535) | 2.26913080 |
| 138 | peptidyl-lysine trimethylation (GO:0018023) | 2.26900178 |
| 139 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.25742760 |
| 140 | mature B cell differentiation (GO:0002335) | 2.25447557 |
| 141 | regulation of necroptotic process (GO:0060544) | 2.24400708 |
| 142 | response to muramyl dipeptide (GO:0032495) | 2.24147030 |
| 143 | lymphoid progenitor cell differentiation (GO:0002320) | 2.23969568 |
| 144 | serine transport (GO:0032329) | 2.21569478 |
| 145 | COPI coating of Golgi vesicle (GO:0048205) | 2.21324919 |
| 146 | Golgi transport vesicle coating (GO:0048200) | 2.21324919 |
| 147 | positive regulation of protein deacetylation (GO:0090312) | 2.21000250 |
| 148 | NIK/NF-kappaB signaling (GO:0038061) | 2.20250370 |
| 149 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.18230649 |
| 150 | necrotic cell death (GO:0070265) | 2.17923868 |
| 151 | thymic T cell selection (GO:0045061) | 2.15636172 |
| 152 | leukocyte degranulation (GO:0043299) | 2.15439090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.54654385 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 4.48637464 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.98062609 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.52872975 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.40191647 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.90929102 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.75388301 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65777606 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.63046538 |
| 10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41905502 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34964425 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34126127 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31478032 |
| 14 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27182662 |
| 15 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.26489427 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.26387003 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.16495432 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.15896411 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.11265407 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.10202734 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.09263249 |
| 22 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.06524529 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.02978983 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.01706483 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.98633633 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.97354432 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.95564480 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.95145499 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91147806 |
| 30 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.90865545 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88317315 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86989223 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.82164670 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.81080325 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.77496000 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77248117 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.76916113 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.76846879 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74298373 |
| 40 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.73743800 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.72117046 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70898181 |
| 43 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.69577305 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.69397826 |
| 45 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61497695 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.60955890 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60492277 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59635313 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54013819 |
| 50 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.53891565 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48965956 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.48361852 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47746656 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46700176 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44686681 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.43188262 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42248114 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.41394476 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40009837 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37925982 |
| 61 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.36656288 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36021298 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35123196 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30816790 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29014572 |
| 66 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26767896 |
| 67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23211177 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.23117386 |
| 69 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.21201394 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20188363 |
| 71 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20066599 |
| 72 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.18988306 |
| 73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17337242 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15299303 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14650628 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13621740 |
| 77 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13578093 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13342408 |
| 79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12064980 |
| 80 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.09296068 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09022871 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07880610 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05590425 |
| 84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05244676 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04948906 |
| 86 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04941224 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04172255 |
| 88 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02484456 |
| 89 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.01162510 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01038872 |
| 91 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00397572 |
| 92 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00067283 |
| 93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99203477 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96624797 |
| 95 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96171266 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95870762 |
| 97 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.94310537 |
| 98 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94133549 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94116528 |
| 100 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.93064616 |
| 101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91732519 |
| 102 | P300_27268052_Chip-Seq_Bcells_Human | 0.90000942 |
| 103 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89764919 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89088573 |
| 105 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88668259 |
| 106 | GATA3_26560356_Chip-Seq_TH1_Human | 0.88446948 |
| 107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87370568 |
| 108 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87274726 |
| 109 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86106760 |
| 110 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.85615800 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85333633 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84911251 |
| 113 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.84665493 |
| 114 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.84637034 |
| 115 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.84552160 |
| 116 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84437926 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.84086630 |
| 118 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83839097 |
| 119 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.82283112 |
| 120 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80255702 |
| 121 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80104203 |
| 122 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79201479 |
| 123 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78919271 |
| 124 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.78552916 |
| 125 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.78496027 |
| 126 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74312100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 3.10276840 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.09659360 |
| 3 | MP0000685_abnormal_immune_system | 2.92496204 |
| 4 | MP0002166_altered_tumor_susceptibility | 2.74364008 |
| 5 | MP0005671_abnormal_response_to | 2.68751019 |
| 6 | MP0005174_abnormal_tail_pigmentation | 2.65345937 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.64737011 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.43841315 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.37408608 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.23531186 |
| 11 | MP0001873_stomach_inflammation | 2.18225647 |
| 12 | MP0001790_abnormal_immune_system | 2.12625967 |
| 13 | MP0005387_immune_system_phenotype | 2.12625967 |
| 14 | MP0001800_abnormal_humoral_immune | 2.10496423 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.10151554 |
| 16 | MP0005025_abnormal_response_to | 1.98668843 |
| 17 | MP0002396_abnormal_hematopoietic_system | 1.98316134 |
| 18 | MP0009785_altered_susceptibility_to | 1.94090131 |
| 19 | MP0002419_abnormal_innate_immunity | 1.92230467 |
| 20 | MP0003300_gastrointestinal_ulcer | 1.92077042 |
| 21 | MP0002723_abnormal_immune_serum | 1.87798012 |
| 22 | MP0002420_abnormal_adaptive_immunity | 1.81740325 |
| 23 | MP0001819_abnormal_immune_cell | 1.79037139 |
| 24 | MP0002909_abnormal_adrenal_gland | 1.78706415 |
| 25 | MP0002452_abnormal_antigen_presenting | 1.77533469 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.75959787 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.75668602 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 1.74465057 |
| 29 | MP0002006_tumorigenesis | 1.72013441 |
| 30 | MP0005365_abnormal_bile_salt | 1.69786602 |
| 31 | MP0002398_abnormal_bone_marrow | 1.66378675 |
| 32 | MP0003436_decreased_susceptibility_to | 1.63579766 |
| 33 | MP0004130_abnormal_muscle_cell | 1.62978584 |
| 34 | MP0009840_abnormal_foam_cell | 1.62531519 |
| 35 | MP0003866_abnormal_defecation | 1.60803746 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.60081511 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.54480614 |
| 38 | MP0000716_abnormal_immune_system | 1.50892107 |
| 39 | MP0001853_heart_inflammation | 1.48511422 |
| 40 | MP0005075_abnormal_melanosome_morpholog | 1.48355045 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.48110466 |
| 42 | MP0004947_skin_inflammation | 1.47386493 |
| 43 | MP0002254_reproductive_system_inflammat | 1.45617562 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.42505980 |
| 45 | MP0003724_increased_susceptibility_to | 1.41520735 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.40158394 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.37693325 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.36605784 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.36605784 |
| 50 | MP0002693_abnormal_pancreas_physiology | 1.36509333 |
| 51 | MP0002132_abnormal_respiratory_system | 1.36323720 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.36067274 |
| 53 | MP0002928_abnormal_bile_duct | 1.34434030 |
| 54 | MP0008469_abnormal_protein_level | 1.30221518 |
| 55 | MP0001851_eye_inflammation | 1.27892633 |
| 56 | MP0002722_abnormal_immune_system | 1.27410449 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.27153050 |
| 58 | MP0000604_amyloidosis | 1.25967121 |
| 59 | MP0002638_abnormal_pupillary_reflex | 1.25739275 |
| 60 | MP0008961_abnormal_basal_metabolism | 1.24574655 |
| 61 | MP0002429_abnormal_blood_cell | 1.24340587 |
| 62 | MP0002009_preneoplasia | 1.23734759 |
| 63 | MP0004381_abnormal_hair_follicle | 1.21585426 |
| 64 | MP0003828_pulmonary_edema | 1.21005271 |
| 65 | MP0010329_abnormal_lipoprotein_level | 1.18526671 |
| 66 | MP0005310_abnormal_salivary_gland | 1.14094916 |
| 67 | MP0002095_abnormal_skin_pigmentation | 1.13987053 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.12562079 |
| 69 | MP0000703_abnormal_thymus_morphology | 1.12495744 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.09927647 |
| 71 | MP0003868_abnormal_feces_composition | 1.09176946 |
| 72 | MP0005379_endocrine/exocrine_gland_phen | 1.06679968 |
| 73 | MP0003045_fibrosis | 1.06612158 |
| 74 | MP0002405_respiratory_system_inflammati | 1.06419050 |
| 75 | MP0001502_abnormal_circadian_rhythm | 1.04560003 |
| 76 | MP0004147_increased_porphyrin_level | 1.04356844 |
| 77 | MP0000609_abnormal_liver_physiology | 1.03608043 |
| 78 | MP0001944_abnormal_pancreas_morphology | 1.03543505 |
| 79 | MP0001765_abnormal_ion_homeostasis | 1.02239181 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01859324 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 1.01739182 |
| 82 | MP0004883_abnormal_blood_vessel | 1.01163324 |
| 83 | MP0001666_abnormal_nutrient_absorption | 0.99905634 |
| 84 | MP0003329_amyloid_beta_deposits | 0.97929754 |
| 85 | MP0009764_decreased_sensitivity_to | 0.97838577 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.97557750 |
| 87 | MP0005083_abnormal_biliary_tract | 0.97471487 |
| 88 | MP0008569_lethality_at_weaning | 0.97317767 |
| 89 | MP0002078_abnormal_glucose_homeostasis | 0.95074293 |
| 90 | MP0002118_abnormal_lipid_homeostasis | 0.92103708 |
| 91 | MP0003075_altered_response_to | 0.91932932 |
| 92 | MP0003252_abnormal_bile_duct | 0.91713077 |
| 93 | MP0005220_abnormal_exocrine_pancreas | 0.91349487 |
| 94 | MP0009643_abnormal_urine_homeostasis | 0.88880148 |
| 95 | MP0001501_abnormal_sleep_pattern | 0.86530249 |
| 96 | MP0001663_abnormal_digestive_system | 0.86330469 |
| 97 | MP0003303_peritoneal_inflammation | 0.85857623 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.85784657 |
| 99 | MP0009278_abnormal_bone_marrow | 0.85351439 |
| 100 | MP0002971_abnormal_brown_adipose | 0.84475538 |
| 101 | MP0004043_abnormal_pH_regulation | 0.84305183 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.82107729 |
| 103 | MP0004484_altered_response_of | 0.82063355 |
| 104 | MP0005535_abnormal_body_temperature | 0.81384390 |
| 105 | MP0005164_abnormal_response_to | 0.80024762 |
| 106 | MP0005636_abnormal_mineral_homeostasis | 0.79568861 |
| 107 | MP0005166_decreased_susceptibility_to | 0.79548912 |
| 108 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78389895 |
| 109 | MP0009763_increased_sensitivity_to | 0.77918631 |
| 110 | MP0004510_myositis | 0.77763975 |
| 111 | MP0005551_abnormal_eye_electrophysiolog | 0.77176389 |
| 112 | MP0000013_abnormal_adipose_tissue | 0.76728038 |
| 113 | MP0002277_abnormal_respiratory_mucosa | 0.76638389 |
| 114 | MP0002933_joint_inflammation | 0.76478648 |
| 115 | MP0000371_diluted_coat_color | 0.75625424 |
| 116 | MP0008260_abnormal_autophagy | 0.75416737 |
| 117 | MP0009642_abnormal_blood_homeostasis | 0.75361063 |
| 118 | MP0005334_abnormal_fat_pad | 0.75178819 |
| 119 | MP0000249_abnormal_blood_vessel | 0.74712860 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.74673962 |
| 121 | MP0006082_CNS_inflammation | 0.73492641 |
| 122 | MP0003690_abnormal_glial_cell | 0.72138595 |
| 123 | MP0003879_abnormal_hair_cell | 0.71584977 |
| 124 | MP0000858_altered_metastatic_potential | 0.69221387 |
| 125 | MP0005390_skeleton_phenotype | 0.68228649 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.64867902 |
| 127 | MP0002019_abnormal_tumor_incidence | 0.62857186 |
| 128 | MP0003787_abnormal_imprinting | 0.56491795 |
| 129 | MP0008004_abnormal_stomach_pH | 0.55140237 |
| 130 | MP0003795_abnormal_bone_structure | 0.53975522 |
| 131 | MP0005451_abnormal_body_composition | 0.52447696 |
| 132 | MP0009115_abnormal_fat_cell | 0.51833885 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.49521670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.16943285 |
| 2 | Orchitis (HP:0100796) | 4.09514971 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.08835782 |
| 4 | Optic neuritis (HP:0100653) | 4.08835782 |
| 5 | Chronic otitis media (HP:0000389) | 4.01404906 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 3.89856140 |
| 7 | Hypoplasia of the thymus (HP:0000778) | 3.72537679 |
| 8 | Encephalitis (HP:0002383) | 3.60530952 |
| 9 | Recurrent viral infections (HP:0004429) | 3.47075173 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 3.42131795 |
| 11 | Obstructive lung disease (HP:0006536) | 3.42131795 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 3.41268149 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.36166474 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.27059955 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.25732228 |
| 16 | Prolonged bleeding time (HP:0003010) | 3.18020751 |
| 17 | Leukocytosis (HP:0001974) | 3.16127715 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.14614643 |
| 19 | Pulmonary infiltrates (HP:0002113) | 3.13230070 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.13098094 |
| 21 | Abnormality of B cell number (HP:0010975) | 3.09338936 |
| 22 | B lymphocytopenia (HP:0010976) | 3.09338936 |
| 23 | Recurrent abscess formation (HP:0002722) | 3.05759926 |
| 24 | Dysostosis multiplex (HP:0000943) | 3.03046559 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.00750690 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.00750690 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 2.99774489 |
| 28 | Inflammation of the large intestine (HP:0002037) | 2.98414748 |
| 29 | Abnormality of eosinophils (HP:0001879) | 2.94956178 |
| 30 | Keratoconjunctivitis sicca (HP:0001097) | 2.93931852 |
| 31 | Hemoptysis (HP:0002105) | 2.91638213 |
| 32 | Gastrointestinal inflammation (HP:0004386) | 2.91327512 |
| 33 | Chest pain (HP:0100749) | 2.88496253 |
| 34 | Colitis (HP:0002583) | 2.88486341 |
| 35 | Spontaneous hematomas (HP:0007420) | 2.84610988 |
| 36 | Keratoconjunctivitis (HP:0001096) | 2.84386479 |
| 37 | Autoimmune hemolytic anemia (HP:0001890) | 2.83012967 |
| 38 | Stomach cancer (HP:0012126) | 2.77978148 |
| 39 | Recurrent skin infections (HP:0001581) | 2.77680813 |
| 40 | Abnormality of the fingertips (HP:0001211) | 2.77060117 |
| 41 | IgG deficiency (HP:0004315) | 2.74621658 |
| 42 | Agammaglobulinemia (HP:0004432) | 2.74330423 |
| 43 | Hypoproteinemia (HP:0003075) | 2.73010509 |
| 44 | Decreased circulating renin level (HP:0003351) | 2.72879032 |
| 45 | Recurrent bronchitis (HP:0002837) | 2.72211015 |
| 46 | IgM deficiency (HP:0002850) | 2.70576981 |
| 47 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.68819104 |
| 48 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.66712143 |
| 49 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.66712143 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.66712143 |
| 51 | Epistaxis (HP:0000421) | 2.65240394 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.64887386 |
| 53 | Myositis (HP:0100614) | 2.59606840 |
| 54 | Impaired platelet aggregation (HP:0003540) | 2.55100472 |
| 55 | Abnormal platelet function (HP:0011869) | 2.55100472 |
| 56 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.55046630 |
| 57 | Abnormality of the pleura (HP:0002103) | 2.54859052 |
| 58 | Cellulitis (HP:0100658) | 2.52071002 |
| 59 | Pulmonary embolism (HP:0002204) | 2.51737246 |
| 60 | T lymphocytopenia (HP:0005403) | 2.50693859 |
| 61 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50648864 |
| 62 | Abnormality of the prostate (HP:0008775) | 2.47838029 |
| 63 | Recurrent sinusitis (HP:0011108) | 2.47249933 |
| 64 | Urticaria (HP:0001025) | 2.45272583 |
| 65 | Arterial thrombosis (HP:0004420) | 2.44632264 |
| 66 | Mucopolysacchariduria (HP:0008155) | 2.43860478 |
| 67 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.43860478 |
| 68 | Abnormality of T cells (HP:0002843) | 2.42937532 |
| 69 | Abnormality of T cell physiology (HP:0011840) | 2.41296816 |
| 70 | Loss of speech (HP:0002371) | 2.40080558 |
| 71 | Gingival bleeding (HP:0000225) | 2.39170045 |
| 72 | Thoracic kyphosis (HP:0002942) | 2.35835503 |
| 73 | Supranuclear gaze palsy (HP:0000605) | 2.35128414 |
| 74 | Eczematoid dermatitis (HP:0000976) | 2.34759056 |
| 75 | Thyroiditis (HP:0100646) | 2.34039745 |
| 76 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.31119785 |
| 77 | Papilledema (HP:0001085) | 2.30459228 |
| 78 | Increased IgM level (HP:0003496) | 2.30197271 |
| 79 | Abnormality of T cell number (HP:0011839) | 2.30123591 |
| 80 | Gastrointestinal stroma tumor (HP:0100723) | 2.29462070 |
| 81 | Meningitis (HP:0001287) | 2.29017157 |
| 82 | Absent/shortened dynein arms (HP:0200106) | 2.28789072 |
| 83 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.28789072 |
| 84 | Hypochromic anemia (HP:0001931) | 2.28016275 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 2.26561341 |
| 86 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.25292881 |
| 87 | Chronic diarrhea (HP:0002028) | 2.23498522 |
| 88 | Hypochromic microcytic anemia (HP:0004840) | 2.22855287 |
| 89 | Mediastinal lymphadenopathy (HP:0100721) | 2.22732471 |
| 90 | Periodontitis (HP:0000704) | 2.21753468 |
| 91 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.20554506 |
| 92 | Hypoglycemic coma (HP:0001325) | 2.19820131 |
| 93 | Hypothermia (HP:0002045) | 2.18285261 |
| 94 | Combined immunodeficiency (HP:0005387) | 2.18165686 |
| 95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.18034128 |
| 96 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.17516967 |
| 97 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.17516967 |
| 98 | Abnormality of glycolipid metabolism (HP:0010969) | 2.17516967 |
| 99 | Gangrene (HP:0100758) | 2.16608533 |
| 100 | Neurodegeneration (HP:0002180) | 2.15614519 |
| 101 | Ketoacidosis (HP:0001993) | 2.14996578 |
| 102 | Fatigue (HP:0012378) | 2.14571011 |
| 103 | Slow saccadic eye movements (HP:0000514) | 2.13337475 |
| 104 | Increased IgE level (HP:0003212) | 2.12131307 |
| 105 | Ketosis (HP:0001946) | 2.11783936 |
| 106 | Nasal polyposis (HP:0100582) | 2.11595536 |
| 107 | Late onset (HP:0003584) | 2.11591557 |
| 108 | Alveolar cell carcinoma (HP:0006519) | 2.11288572 |
| 109 | Thrombocytosis (HP:0001894) | 2.10661472 |
| 110 | Sepsis (HP:0100806) | 2.10273948 |
| 111 | Abnormality of the nasal mucosa (HP:0000433) | 2.09909611 |
| 112 | Severe combined immunodeficiency (HP:0004430) | 2.09124462 |
| 113 | Interstitial pulmonary disease (HP:0006530) | 2.07143343 |
| 114 | Hypoglycemic seizures (HP:0002173) | 2.04228435 |
| 115 | Abnormality of macrophages (HP:0004311) | 2.03817442 |
| 116 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.03447254 |
| 117 | Bronchitis (HP:0012387) | 2.02030145 |
| 118 | Acute lymphatic leukemia (HP:0006721) | 2.01478756 |
| 119 | Episodic fever (HP:0001954) | 2.00432819 |
| 120 | Anorexia (HP:0002039) | 1.99492042 |
| 121 | Microcytic anemia (HP:0001935) | 1.98774995 |
| 122 | Reduced antithrombin III activity (HP:0001976) | 1.97876924 |
| 123 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.96718535 |
| 124 | Granulocytopenia (HP:0001913) | 1.95414182 |
| 125 | Progressive neurologic deterioration (HP:0002344) | 1.94644935 |
| 126 | Abnormality of the thoracic spine (HP:0100711) | 1.94611486 |
| 127 | Osteomyelitis (HP:0002754) | 1.94592576 |
| 128 | Autoimmune thrombocytopenia (HP:0001973) | 1.94176597 |
| 129 | Petechiae (HP:0000967) | 1.94015062 |
| 130 | Broad face (HP:0000283) | 1.93528583 |
| 131 | Thyroid-stimulating hormone excess (HP:0002925) | 1.92685321 |
| 132 | Joint swelling (HP:0001386) | 1.92457473 |
| 133 | Symptomatic seizures (HP:0011145) | 1.91728312 |
| 134 | Chronic sinusitis (HP:0011109) | 1.90964186 |
| 135 | Skin rash (HP:0000988) | 1.90761001 |
| 136 | Generalized aminoaciduria (HP:0002909) | 1.90299819 |
| 137 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89549044 |
| 138 | Keratitis (HP:0000491) | 1.89052276 |
| 139 | Papilloma (HP:0012740) | 1.88486099 |
| 140 | Verrucae (HP:0200043) | 1.88486099 |
| 141 | Vasculitis (HP:0002633) | 1.85570174 |
| 142 | Amyloidosis (HP:0011034) | 1.84368166 |
| 143 | Emphysema (HP:0002097) | 1.84082545 |
| 144 | Gingivitis (HP:0000230) | 1.82669592 |
| 145 | Eosinophilia (HP:0001880) | 1.80784098 |
| 146 | Aplastic anemia (HP:0001915) | 1.80668207 |
| 147 | Restrictive lung disease (HP:0002091) | 1.79163528 |
| 148 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.78094372 |
| 149 | Lymphopenia (HP:0001888) | 1.78052706 |
| 150 | Pustule (HP:0200039) | 1.77781538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 3.48661226 |
| 2 | TNIK | 3.25324978 |
| 3 | FLT3 | 2.97662892 |
| 4 | TAOK3 | 2.87009560 |
| 5 | MAP3K13 | 2.86464132 |
| 6 | ERN1 | 2.72516058 |
| 7 | MAP4K1 | 2.68879926 |
| 8 | INSRR | 2.64686778 |
| 9 | FRK | 2.35345357 |
| 10 | SIK2 | 2.11081198 |
| 11 | RIPK4 | 2.05203708 |
| 12 | TYK2 | 2.01056390 |
| 13 | JAK3 | 1.92264334 |
| 14 | IKBKE | 1.88678307 |
| 15 | BTK | 1.87586755 |
| 16 | TEC | 1.80448168 |
| 17 | FES | 1.62609952 |
| 18 | TBK1 | 1.60974462 |
| 19 | BMPR2 | 1.59585067 |
| 20 | ZAP70 | 1.58129268 |
| 21 | IRAK4 | 1.56049509 |
| 22 | TXK | 1.55560285 |
| 23 | MAP3K7 | 1.51852347 |
| 24 | FGFR4 | 1.50128332 |
| 25 | MAPK15 | 1.49506243 |
| 26 | CSF1R | 1.46440080 |
| 27 | JAK1 | 1.44610322 |
| 28 | BRD4 | 1.42266108 |
| 29 | HIPK2 | 1.37406159 |
| 30 | SYK | 1.36564636 |
| 31 | SIK1 | 1.34129365 |
| 32 | TGFBR2 | 1.34092553 |
| 33 | CAMKK2 | 1.28944432 |
| 34 | ITK | 1.22148846 |
| 35 | MARK3 | 1.12696827 |
| 36 | HCK | 1.10489932 |
| 37 | MAP3K14 | 1.10084514 |
| 38 | BCKDK | 1.08927105 |
| 39 | CAMK1 | 1.06269608 |
| 40 | LCK | 1.05727930 |
| 41 | IRAK3 | 1.04627343 |
| 42 | BLK | 1.02022073 |
| 43 | JAK2 | 1.00846386 |
| 44 | MAP2K3 | 1.00829228 |
| 45 | MARK2 | 1.00159300 |
| 46 | SCYL2 | 0.99968826 |
| 47 | ACVR1B | 0.99660433 |
| 48 | TESK2 | 0.98628808 |
| 49 | MAPKAPK3 | 0.97630597 |
| 50 | TRIB3 | 0.97374707 |
| 51 | CAMK1D | 0.97052975 |
| 52 | CAMK1G | 0.95920598 |
| 53 | GRK6 | 0.95455618 |
| 54 | PIK3CG | 0.92437313 |
| 55 | MUSK | 0.91686892 |
| 56 | PKN2 | 0.91601550 |
| 57 | PTK6 | 0.89389976 |
| 58 | RIPK1 | 0.88529296 |
| 59 | FGR | 0.87041163 |
| 60 | STK16 | 0.84396791 |
| 61 | LYN | 0.84307833 |
| 62 | PTK2B | 0.84231402 |
| 63 | EEF2K | 0.82882072 |
| 64 | TTN | 0.81500119 |
| 65 | ADRBK2 | 0.81344590 |
| 66 | NLK | 0.81237220 |
| 67 | MAPK11 | 0.80591695 |
| 68 | DYRK1B | 0.79123299 |
| 69 | YES1 | 0.79031722 |
| 70 | EPHA4 | 0.78182520 |
| 71 | TLK1 | 0.75975908 |
| 72 | TRPM7 | 0.73908847 |
| 73 | PIM1 | 0.73610107 |
| 74 | MAPK12 | 0.73243791 |
| 75 | PRKAA2 | 0.72437644 |
| 76 | CDK19 | 0.69441653 |
| 77 | MAP3K1 | 0.67733767 |
| 78 | FGFR3 | 0.66338860 |
| 79 | DYRK3 | 0.66086555 |
| 80 | LRRK2 | 0.65885144 |
| 81 | TNK2 | 0.65604485 |
| 82 | MAP3K11 | 0.65129199 |
| 83 | MATK | 0.64963350 |
| 84 | MAP2K2 | 0.64513668 |
| 85 | PRPF4B | 0.64366930 |
| 86 | MAP3K6 | 0.63167377 |
| 87 | PHKG1 | 0.60364059 |
| 88 | PHKG2 | 0.60364059 |
| 89 | DAPK1 | 0.60273558 |
| 90 | PRKD2 | 0.59325272 |
| 91 | EPHA3 | 0.58386468 |
| 92 | CSK | 0.55732824 |
| 93 | SIK3 | 0.54436802 |
| 94 | DYRK1A | 0.54289457 |
| 95 | RAF1 | 0.52580199 |
| 96 | BMPR1B | 0.52460234 |
| 97 | PDPK1 | 0.50790890 |
| 98 | GRK7 | 0.50575358 |
| 99 | KSR2 | 0.50439799 |
| 100 | RPS6KA6 | 0.50363252 |
| 101 | NTRK3 | 0.50002111 |
| 102 | FYN | 0.49754941 |
| 103 | KDR | 0.49567241 |
| 104 | CDC42BPA | 0.48776949 |
| 105 | PRKCH | 0.48026688 |
| 106 | CAMKK1 | 0.47359796 |
| 107 | ABL1 | 0.46411811 |
| 108 | DAPK2 | 0.46078801 |
| 109 | EPHB1 | 0.45402452 |
| 110 | MAPK13 | 0.44062872 |
| 111 | CAMK4 | 0.43646923 |
| 112 | CHUK | 0.43432765 |
| 113 | MAP3K2 | 0.43432547 |
| 114 | MAP4K2 | 0.42987552 |
| 115 | IRAK1 | 0.42579972 |
| 116 | IKBKB | 0.42086361 |
| 117 | RPS6KL1 | 0.42082479 |
| 118 | RPS6KC1 | 0.42082479 |
| 119 | MAP2K6 | 0.41361449 |
| 120 | STK38 | 0.40737204 |
| 121 | CLK1 | 0.40432275 |
| 122 | STK11 | 0.39877179 |
| 123 | PDK1 | 0.38851434 |
| 124 | RET | 0.38291486 |
| 125 | MAP2K7 | 0.38048533 |
| 126 | IRAK2 | 0.38022214 |
| 127 | MAP2K4 | 0.37530230 |
| 128 | PRKCQ | 0.37509623 |
| 129 | MAPK7 | 0.36802891 |
| 130 | MAP3K10 | 0.36151484 |
| 131 | PINK1 | 0.35879842 |
| 132 | ADRBK1 | 0.34965302 |
| 133 | MAPK3 | 0.34820263 |
| 134 | MAP3K5 | 0.33424843 |
| 135 | PIK3CA | 0.33114471 |
| 136 | WNK1 | 0.31458114 |
| 137 | OXSR1 | 0.30087208 |
| 138 | PRKD1 | 0.29597501 |
| 139 | NUAK1 | 0.28993341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.41932662 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.40919640 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.33593363 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.15390474 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.12194969 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.87362855 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.85532473 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.51994319 |
| 9 | ABC transporters_Homo sapiens_hsa02010 | 2.18143154 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.16955778 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.08567200 |
| 12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.00664127 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.71911921 |
| 14 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.69928892 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64241873 |
| 16 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.61550296 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.59835818 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.57643176 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.57433767 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.52690053 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44143278 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.41804961 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38156946 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.34362399 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.29675168 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.29306426 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.27936745 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27809082 |
| 29 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.26765647 |
| 30 | Lysine degradation_Homo sapiens_hsa00310 | 1.24265698 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.24075670 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 1.22392371 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.21857869 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.19936878 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19694822 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18367700 |
| 37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.17630875 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16775902 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12536993 |
| 40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.08487336 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.07423657 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05759525 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05647155 |
| 44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.03566290 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.98955471 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.98929923 |
| 47 | Circadian rhythm_Homo sapiens_hsa04710 | 0.98436657 |
| 48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97581785 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97107284 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.96733700 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96546267 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.96535239 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 0.96222769 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.95456330 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95082538 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 0.94933728 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91378130 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89471121 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 0.89452464 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.87151068 |
| 61 | Protein export_Homo sapiens_hsa03060 | 0.86309899 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.86271547 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.85905462 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85330853 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85174780 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82302754 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80808985 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80762760 |
| 69 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.80188788 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.79881321 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.79235469 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78093333 |
| 73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74759390 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74662182 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.74223005 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73896736 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.73750056 |
| 78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.71571074 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71263781 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.69221393 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69000561 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68704645 |
| 83 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.68475545 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67114872 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66920171 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65641665 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64865492 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62625495 |
| 89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61757060 |
| 90 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61535697 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61115400 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60541093 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.60255033 |
| 94 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58771403 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57526342 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57387045 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.56324815 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55926312 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55609563 |
| 100 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55227364 |
| 101 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54563937 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54411733 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54119360 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54024655 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.53921212 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.53895421 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52446154 |
| 108 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52161474 |
| 109 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51809691 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51777610 |
| 111 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51643925 |
| 112 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49821139 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47867320 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47606866 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47476804 |
| 116 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45976596 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44889399 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44785632 |
| 119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44412682 |
| 120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44262779 |
| 121 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43977421 |
| 122 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.43794022 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42636795 |
| 124 | Salivary secretion_Homo sapiens_hsa04970 | 0.41571743 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41098073 |
| 126 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39968038 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39783923 |
| 128 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38915428 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38842481 |
| 130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38767371 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.38668329 |
| 132 | Taste transduction_Homo sapiens_hsa04742 | 0.38631927 |
| 133 | Salmonella infection_Homo sapiens_hsa05132 | 0.37622942 |
| 134 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36056551 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35809521 |
| 136 | Olfactory transduction_Homo sapiens_hsa04740 | 0.35060189 |
| 137 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33800762 |
| 138 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.33085162 |
| 139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30913035 |
| 140 | Renin secretion_Homo sapiens_hsa04924 | 0.30866926 |
| 141 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28937344 |
| 142 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28560303 |
| 143 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.25127629 |

